Cargando…

PandT Committees - Black Boxes Versus AMCP Format, and What Is the True Cost and Value of Pimecrolimus

Detalles Bibliográficos
Autor principal:	Curtiss, Frederic R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2005
Materias:	Editorial Subjects In This Issue
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438156/ https://www.ncbi.nlm.nih.gov/pubmed/15667238 http://dx.doi.org/10.18553/jmcp.2005.11.1.93

Ejemplares similares

Development of a Complementary and Alternative Medicine (CAM) Pharmacy and Therapeutics (PandT) Subcommittee and CAM Guide for Providers
por: Dunn, Jeffery D., et al.
Publicado: (2005)

The AMCP Format for Formulary Submissions: Welcome to Version 4.0: The AMCP Format Executive Committee
Publicado: (2016)

Heartburn in Consumer-Directed Health Care and the Cost Outcomes of Therapeutic Maximum Allowable Cost
por: Curtiss, Frederic R.
Publicado: (2006)

Pharmacoeconomics - Determiniation of the Cost-Effectiveness of Helicobacter Pylori Eradication
por: Curtiss, Frederic R.
Publicado: (2003)

COPD - Whose Burden, How Large, and What to Do About It?
por: Curtiss, Frederic R.
Publicado: (2005)

Which Triptan? - Opportunity for Same or Better Outcomes at Lower Cost
por: Curtiss, Frederic R.
Publicado: (2004)

Clinical, Service, and Cost Outcomes of Computerized Prescription Order Entry
por: Curtiss, Frederic R.
Publicado: (2005)

David and Goliath - Employer Takes on Health Care Cost Management
por: Curtiss, Frederic R.
Publicado: (2004)

What Evidence Supports Guidelines for Use of ACE Inhibitors and ARBs in Diabetes?
por: Curtiss, Frederic R.
Publicado: (2006)

Contractual Arrangements Between HMOs and Medical Groups to Manage Drug Costs
por: Curtiss, Frederic R.
Publicado: (2003)

Clinical, Service, and Cost Outcomes of Drug Coverage Edits and Quanitity Limits
por: Curtiss, Frederic R.
Publicado: (2003)

Reducing the Risk of Fractures - The Options Narrow for Cost-Effective Therapeutic Alternatives
por: Curtiss, Frederic R.
Publicado: (2004)

Does Member Cost Sharing Pose a Threat to Desirable Patient Outcomes?
por: Curtiss, Frederic R.
Publicado: (2004)

Finding the Truth About Health Care Cost Drivers - Price Versus Utilization Factors
por: Curtiss, Frederic R.
Publicado: (2003)

Evidence-Based Medicine: Are SSRIs More Effective Than Placebo and What Length of Therapy is Enough?
por: Curtiss, Frederic R.
Publicado: (2005)

Step-Therapy Edits for PPIs and COX-2 Drugs - What We Do and Do Not Know
por: Curtiss, Frederic R.
Publicado: (2004)

Value for Money in Disease Management of Acute Coronary Syndrome - The Price of Aspirin to Reduce the Costs of ACS
por: Curtiss, Frederic R.
Publicado: (2005)

Pressure on Pharmacy Benefit Managers for Disclosure and Demonstration of Value - Rebates and Drug Benegit Cost Savings
por: Curtiss, Frederic R.
Publicado: (2003)

Effects of Physician Report Cards, Knowledge of Drug Prices, and Financial Incentives in Prescription Drug Costs
por: Curtiss, Frederic R.
Publicado: (2003)

AMCP Partnership Forum: Principles for Sound Pharmacy and Therapeutics (P&T) Committee Practices: What’s Next?
Publicado: (2020)

Evolution of the AMCP Format for Formulary Submissions
por: Watkins, John B., et al.
Publicado: (2020)

PAND2 Test results
por: Bocci, V, et al.
Publicado: (1996)

Clinical Pharmacist Intervention in a Primary Care Medical Group Reduces Financial Losses
por: Curtiss, Frederic R.
Publicado: (2004)

Best Value for Money in Triptans
por: Curtiss, Frederic R.
Publicado: (2005)

Evidence-Based Medicine: Which Drugs Are Truly Contraindicated for Use in Older Adults?
por: Curtiss, Frederic R.
Publicado: (2005)

Effective Integration of Medical and Pharmacy Claims to Better Protect Patient Safety - A Long Road Yet to Travel
por: Curtiss, Frederic R.
Publicado: (2007)

United States, The Last Venue for Direct-to-Customer Advertising, Props Up the Erectile Dysfunction Market
por: Curtiss, Frederic R.
Publicado: (2005)

OTC Omeprazole for Your Heartburn - Enormous Value-for-Money Opportunity
por: Curtiss, Frederic R.
Publicado: (2004)

Outcomes of Sword Swallowing and Pharmaceutical Step-Therapy Interventions
por: Curtiss, Frederic R.
Publicado: (2007)

Alternate Managed Care Approaches to Disease Management of Allergic Rhinitis
por: Curtiss, Frederic R.
Publicado: (2004)

Prescription-Equivalent Over-the-Counter Drugs for Allergy, Heartburn, and Cholesterol Reduction
por: Curtiss, Frederic R.
Publicado: (2005)

Disease Management Oppurtunities for IBS - Placebo Versus Active Therapy
por: Curtiss, Frederic R.
Publicado: (2004)

Evidence-Based Medicing: Beware of Results From Randomized Controlled Trials and Research With Administrative Claims Data
por: Curtiss, Frederic R.
Publicado: (2005)

U Can't Touch This With Pharmacotherapy Alone for Weight Loss or Smoking Cessation
por: Curtiss, Frederic R.
Publicado: (2005)

Drug Formulary Decisions - Evaluating the Risks and Benefits of Hormone Replacement Therapy
por: Curtiss, Frederic R.
Publicado: (2004)

3-Tier Drug Benefit Designs Based on Sound Drug Formulary Principles Will Maximize Favorable Outcomes
por: Curtiss, Frederic R.
Publicado: (2004)

Value for Money in Disease Management of Benign Prostatic Hyperplasia
por: Curtiss, Frederic R.
Publicado: (2004)

Does Persistence With Drugs for Alzheimer's Disease Matter?
por: Curtiss, Frederic R.
Publicado: (2005)

Disease Management, Pay-for-Performance, and Clinical Pharmacist Interventions in Diabetes Care
por: Curtiss, Frederic R.
Publicado: (2003)

The Relative Value of Disease Management Programs Versus Drug Manufacturer Rebates
por: Curtiss, Frederic R.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_pt4ln3oiebdmdv7jb1v4h6qdu0